Literature DB >> 9683214

Short-term haemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failure.

P J Cowburn, J G Cleland, J D McArthur, M R MacLean, J J McMurray, H J Dargie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9683214     DOI： 10.1016/S0140-6736(05)77807-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

Review 1.  Hemodynamic effects of bosentan in patients with chronic heart failure.

Authors:  W Kiowski; G Sütsch; E Oechslin; O Bertel
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 2.  Heart failure in 10 years time: focus on pharmacological treatment.

Authors:  J J V McMurray
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 3.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 4.  Clinical experience with endothelin receptor antagonists in chronic heart failure.

Authors:  A Seed; M P Love; J J McMurray
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 5.  Endothelins: pathophysiology and treatment implications in chronic heart failure.

Authors:  John R Teerlink
Journal:  Curr Heart Fail Rep       Date:  2005-12

Review 6.  The role of endothelin receptor antagonists in the treatment of chronic heart failure.

Authors:  W Kiowski; G Sütsch
Journal:  Curr Cardiol Rep       Date:  2001-05       Impact factor: 2.931

Review 7.  Endothelin receptor antagonists and cardiovascular diseases of aging.

Authors:  M P Love; J J McMurray
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 8.  The therapeutic potential of endothelin receptor antagonists in cardiovascular disease.

Authors:  M Barton; W Kiowski
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

9.  Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure.

Authors:  S J Leslie; J C S Spratt; S P McKee; F E Strachan; D E Newby; D B Northridge; M A Denvir; D J Webb
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

Review 10.  Drug therapy in chronic heart failure.

Authors:  D B McKenzie; A J Cowley
Journal:  Postgrad Med J       Date:  2003-11       Impact factor: 2.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.